欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3777/001
药品名称Glatiramer acetate Mylan 40 mg/ml, solution for injection, pre-filled syringe
活性成分
    • glatiramer acetate 40.0 mg/ml
剂型Solution for injection in prefilled syringe
上市许可持有人Mylan bv Dieselweg 25 3752 LB Bunschoten The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
      CLIFT 40 mg/ml Injektionslösung in einer Fertigspritze
    • Denmark (DK)
      Copemyl
    • Belgium (BE)
      Glatiramyl 40 mg/ml, oplossing voor injectie in een voorgevulde spuit
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
      GLATIRAMER/MYLAN
    • Sweden (SE)
    • Norway (NO)
      Copemyl
    • Finland (FI)
    • Portugal (PT)
    • Cyprus (CY)
      Glatiramer Mylan 40mg/ml solution for injection pre-filled syringe
许可日期2017/10/03
最近更新日期2024/04/04
药物ATC编码
    • L03AX13 glatiramer acetate
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase